Last reviewed · How we verify
Prostaglandin F2alpha — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
Prostaglandin F2alpha (Prostaglandin F2alpha) — Danish Headache Center.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Prostaglandin F2alpha TARGET | Prostaglandin F2alpha | Danish Headache Center | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Prostaglandin F2alpha CI watch — RSS
- Prostaglandin F2alpha CI watch — Atom
- Prostaglandin F2alpha CI watch — JSON
- Prostaglandin F2alpha alone — RSS
Cite this brief
Drug Landscape (2026). Prostaglandin F2alpha — Competitive Intelligence Brief. https://druglandscape.com/ci/prostaglandin-f2alpha. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab